Incidence of and risk factors for atrial fibrillation in older adults

Circulation

Volumn 96, Issue 7, 1997, Pages 2455-2461

  Psaty, Bruce M ^a   Manolio, Teri A ^a   Kuller, Lewis H ^a   Kronmal, Richard A ^a   Cushman, Mary ^a   Fried, Linda P ^a   White, Richard ^a   Furberg, Curt D ^a   Rautaharju, Pentti M ^a  

^a Cardiovasc Hlth Stud Coord Ctr   (United States)

Author keywords

Atrial flutter; Epidemiology; Fibrillation; Follow up studies; Risk factors

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; AGING; ANTICOAGULATION; BLOOD PRESSURE REGULATION; ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0030855939     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.7.2455     Document Type: Review

References (37)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution and gender of patients with atrial fibrillation. Arch Intern Med. 1995;155:469-473.
2. Sage JI, Van Uitert RL. Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease. Stroke. 1983;14: 537-540.
3. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet. 19S7;l:526-529.
4. Wolf PA, Abbott RD, Kännel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22:983-988.
5. Boysen G, Nyboe J, Appleyard M, Sorensen PS, Boas J, Somnier F, Jensen G, Schnohr P. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke. 19S8;19:1345-1353.
6. Lake FR, Cullcn KJ, de Kkrk NH, McCall MG, Rosman DL. Atrial fibrillation and mortality in an elderly population. Aust N Z J Mcd. 1989;19:321-326.
7. Kännel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J. 1983;106:389-396.
8. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation. 1991;84: 527-539.
9. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient isché mie attack or minor stroke. Lancet. 1993;342:1255-1262.
10. Pritchett EL. Management of atrial fibrillation. N Engl J Med. 1992;326:1264-1271.
11. Gustafsson C, Asplund K, Britton M, Norrving B, Olsson B, Narke LA. Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective, feuJ. 1992;305:1457-1460.
12. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Mcd. 1994;154:1449-1457.
13. The Stroke Prevention in Atrial Fibrillation Investigators. Bleeding during antithrombotic therapy in patients with atrial fibrillation. Arch Intern Mcd. 1996;156:409-416.
14. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Mcd. 1987; 317:669-674.
15. Rose G, Baxter PJ, Reid DD, McCartney P. Prevalence and prognosis of electrocardiographic findings in middle-aged men. Br Heart J. 1978;40:636-643.
16. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologie features of chronic atrial fibrillation. N EngU Mcd. 19S2;306: 1018-1022.
17. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Bélanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271:840-844.
18. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM, for the CHS Collaborative Research Group. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994;74:236-241.
19. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty B, Rautaharju P, Tracy RP, Weiler PG. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;l:263-276.
20. Tell OS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol. 1993;3: 358-366.
21. Psaty BM.KulIerLH, Bild D, Burke GL, Kittner SJ, Mittelmark M, Price TR, Rautaharju PM, Robbins J. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol. 1995;5:270-277.
22. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M. Assessing the use of medications in the elderly: method and initial results in the Cardiovascular Health Study./ Clin Epidemiol. 1992; 45:683-692.
23. Rautaharju PM, Maclnnis PJ, Warren JW, Wolf HK, Rykers PM, Calhoun HP. Methodology of ECG interpretation in the Dalhousie program: NOVACODE ECG classification procedure for clinical trials and population health surveys. Methods Inf Med. 1990;29: 362-374.
24. Rautaharju PM, Warren JW, Jain U, Wolf HK, Nielsen CL. Cardiac infarction injury score: an electrocardiographic coding scheme for ischémie heart disease. Circulation. 19Sl;64:249-256.
25. Furberg CD, Manolio TA, Psaty BM, Bild DE, Borhani NO, Newman A, Tabatznik B, Rautaharju PM. Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Am J Cardiol. 1992;69:1329-1335.
26. O'Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA. The use of sonography to evaluate carotid atherosclerosis in the elderly: the Cardiovascular Health Study. Stroke. 1991;22:1155-1163.
27. Gardin JM, Wong ND, Bommer W, Klopfenstein HS, Smithe VE, Tabatznick B, Siscovick D, Lobodzinski S, Anton-Culver H, Manolio TA. Echocardiographic design of a multi-center investigation of free-living elderly subjects: the Cardiovascular Health Study, y Am Soc Echocardiogr.-1992;5:63-72.
28. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality control in the Cardiovascular Health Study. Clin Chan. 1995;41:264-270.
29. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S. Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study. Ann Epidemiol. 1995;5:278-285.
30. Aboaf AP, Wolf PS. Paroxysmal atrial fibrillation. Arch Intern Med. 1996;156:362-367.
31. Norusis MJ, for SPSS'lnc. SPSS/PC+ 4.0 Base Manual for the IBM PC/XT/AT and PS/2. Chicago: SPSS Inc, 1990.
32. Cox DR, Oakes D. Analysis of Sunival Data. London, UK: Chapman & Hall; 1984.
33. Matthew JP, Parks R, Savino JS, Friedman AS, Koch Colleen, Mangano DT, Browner WS. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes and resource utilization. JAMA. 1996;276:300-306.
34. Suttorp MJ, Kingma JH, Koomen EM, van't Hof A, Tijssen JGP, Lie Kl. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol. 1993;71:710-713.
35. Takahashi N, Seki A, Imataka K, Fujii J. Clinical features of paroxysmal atrial fibrillation, an observation of 94 patients. 7/wi Heart J. 1981;22:143-149.
36. Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol. 1992;69:963-965.
37. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 1994;89:224-227.